Study Stopped
Undefined
PASCAL Trabeculoplasty
Semi-Automated Patterned Laser Trabeculoplasty
1 other identifier
interventional
24
1 country
1
Brief Summary
Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP). Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM). Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult. We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 5, 2008
CompletedFirst Posted
Study publicly available on registry
December 8, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedMay 30, 2024
May 1, 2024
1 year
December 5, 2008
May 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Intraocular Pressure
During follow-up
Study Arms (1)
Group 1
EXPERIMENTALPatients with open-angle glaucoma
Interventions
Pattern Scan Laser trabeculoplasty
Eligibility Criteria
You may qualify if:
- year-old patients
- Uncontrolled Open angle (Shaffer IV)
- No previous surgical trabeculoplasty or glaucoma surgery
You may not qualify if:
- Patients not willing to participate
- Angle-closure glaucoma
- No clear optical media
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asociación para Evitar la Ceguera en México
Mexico City, Mexico City, 04030, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felix Gil Carrasco, MD
Asociación para Evitar la Ceguera en México
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2008
First Posted
December 8, 2008
Study Start
December 1, 2007
Primary Completion
December 1, 2008
Study Completion
December 1, 2009
Last Updated
May 30, 2024
Record last verified: 2024-05